Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice

  1. Takanori Esaki*,
  2. Michelle Cook*,
  3. Kazuaki Shimoji,
  4. Dennis L. Murphy,
  5. Louis Sokoloff*,§, and
  6. Andrew Holmes
  1. Laboratories of *Cerebral Metabolism and Clinical Science, National Institute of Mental Health, Section on Behavioral Science and Genetics, Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, and Positron Emission Tomography Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892
  1. Contributed by Louis Sokoloff, March 8, 2005

Abstract

There is growing evidence that serotonin (5-hydroxtryptamine, 5-HT) has major influences on brain development in mammals. Genetic and pharmacological disruption of 5-HT signaling during early postnatal development in rodents causes neuroanatomical cortical abnormalities, including malformations in the somatosensory cortex. Possible functional consequences of this developmental perturbation by 5-HT are not yet understood. We have examined the effects of deletion of the 5-HT transporter (5-HTT) gene on somatosensory responses to sensory stimulation in mice. Local cerebral glucose utilization (lCMRglc) was measured by the quantitative 2-deoxy[14C]glucose method during unilateral whisker stimulation in awake adult mice. lCMRglc was increased by stimulation but to a markedly lesser extent in 5-HTT / mice than in 5-HTT +/+ controls in each of four major stations in the whisker-to-barrel cortex pathway (the spinal and principal sensory trigeminal nuclei, the ventral posteromedial thalamic nucleus, and the barrel region of the somatosensory cortex). Lowering brain 5-HT levels by administration of the selective tryptophan hydroxylase inhibitor p-chlorophenylalanine on postnatal days 0 and 1 restored the metabolic responses to functional activation in the whisker-to-barrel cortex pathway in adult 5-HTT / mice. These results indicate that functional deficits in this pathway in 5-HTT / mice may be due to excessive postnatal 5-HT activity. With or without postnatal p-chlorophenylalanine treatment, 5-HTT / mice exhibited lower resting (unstimulated) lCMRglc than did 5-HTT +/+ controls in the whisker-to-barrel cortex pathway and throughout the brain. These findings have implications for understanding the potential long-term consequences of genetic and pharmacological disruption of 5-HT neurotransmission on cerebral functions during critical periods of postnatal development.

Footnotes

  • § To whom correspondence should be addressed at: Laboratory of Cerebral Metabolism, National Institute of Mental Health, Building No. 36, 1A-07, 36 Convent Drive, MSC 4030, Bethesda, MD 20892-4030. E-mail: louissokoloff{at}mail.nih.gov.

  • Abbreviations: 5-HT, 5-hydroxtryptamine (serotonin); 5-HTT, serotonin transporter; 5-HT1BR, 5-HT1B receptor subtype; lCMRglc, local cerebral glucose utilization; MAOA, monoamine oxidase A; PCPA, p-chlorophenylalanine; Pn, postnatal day n.

« Previous | Next Article »Table of Contents